Francisco Leon - 24 Nov 2021 Form 4 Insider Report for Provention Bio, Inc.

Role: Chief Scientific Officer
Signature: /s/ Andrew Drechsler, as attorney-in-fact
Issuer symbol: N/A
Transactions as of: 24 Nov 2021
Net transactions value: +$40,188
Form type: 4
Filing time: 29 Nov 2021, 16:15:13 UTC
Previous filing: 14 May 2021
Next filing: 14 Feb 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PRVB	Common Stock	Purchase	$40,188	+5,550	+0.22%	$7.24	2,573,000	24 Nov 2021	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.24 to $7.25, inclusive. The reporting person undertakes to provide to Provention Bio, Inc., any security holder of Provention Bio, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth herein.

Content

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.24 to $7.25, inclusive. The reporting person undertakes to provide to Provention Bio, Inc., any security holder of Provention Bio, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth herein.